Mark For: OBSIDIO™ trademark registration is intended to cover the categories of pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials comprised of living tissue, namely, hydrogels; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of living tissue, namely, hydrogels; medical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of living tissue, namely, hydrogels; preparations for implantable surgical materials in the nature of implants comprised of living tissue, namely, hydrogels; preparations for implantable hydrogel-based embolics; pharmaceutical preparations, namely, embolization therapy preparations for embolization of tumors; medical preparations for embolization therapy systems; medical preparations for vascular embolization, hemorrhage control, and peripheral hemostasis; pharmaceutical preparations, namely, surgical hydrogel precursors; surgical hydrogel precursors for kits for use in medical and surgical procedures comprised of surgical hydrogel precursors that react to form a medical hydrogel when combined with each other and applicators therefore; medical preparations used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; pharmaceutical preparations, namely, differentiated liquid embolic agents; kits for creating medical hydrogels for vascular embolization procedures, consisting of hydrogel precursors and applicator.
Status
2022-10-29 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Dianna L. Gould
Attorney Docket Number
432469
Timeline
2022-10-25
Application Filed
2022-10-28
Location: NEW APPLICATION PROCESSING
2022-10-28
Status: Live/Pending
2022-10-28
Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
DIANNA L. GOULD FAEGRE DRINKER BIDDLE & REATH LLP 90 SOUTH 7TH STREET 2200 WELLS FARGO CENTER MINNEAPOLIS, MN 55402
Good, Services, and Codes
International Codes:
5
U.S. Codes:
005,006,018,044,046,051,052
International Codes:
10
U.S. Codes:
026,039,044
Type Code
Type
GS0051
Pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials comprised of living tissue, namely, hydrogels; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of living tissue, namely, hydrogels; medical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of living tissue, namely, hydrogels; preparations for implantable surgical materials in the nature of implants comprised of living tissue, namely, hydrogels; preparations for implantable hydrogel-based embolics; pharmaceutical preparations, namely, embolization therapy preparations for embolization of tumors; medical preparations for embolization therapy systems; medical preparations for vascular embolization, hemorrhage control, and peripheral hemostasis; pharmaceutical preparations, namely, surgical hydrogel precursors; surgical hydrogel precursors for kits for use in medical and surgical procedures comprised of surgical hydrogel precursors that react to form a medical hydrogel when combined with each other and applicators therefore; medical preparations used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; pharmaceutical preparations, namely, differentiated liquid embolic agents; kits for creating medical hydrogels for vascular embolization procedures, consisting of hydrogel precursors and applicator
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.